Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York.
宾夕法尼亚州韦恩，2024年9月10日（GLOBE NEWSWIRE）——专注于开发免疫炎症性疾病新候选药物的临床阶段生物制药公司Aclaris Therapeutics, Inc.（纳斯达克股票代码：ACRS）今天宣布，Aclaris管理团队成员将在美国东部时间2024年9月17日星期二上午8点参加2024年Cantor全球医疗保健会议期间的炉边谈话纽约，纽约。
A webcast of the fireside chat may be accessed through the "Events" page of the "Investors" section of Aclaris' website, . The webcast will be archived for at least 30 days on the Aclaris website.
可以通过Aclaris网站 “投资者” 部分的 “活动” 页面访问炉边聊天的网络直播,.该网络直播将在Aclaris网站上存档至少30天。
About Aclaris Therapeutics, Inc.
关于 Aclaris Therapeutics, Inc
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit .
Aclaris Therapeutics, Inc. 是一家处于临床阶段的生物制药公司，正在开发一系列新的候选药物，以满足缺乏令人满意的治疗选择的免疫炎性疾病患者的需求。该公司拥有多阶段候选药物组合，由探索蛋白激酶调节的强大研发引擎提供支持。如需更多信息，请访问。
Aclaris Therapeutics Contact:
Aclaris 治疗联系人：
investors@aclaristx.com
investors@aclaristx.com
